pimozide has been researched along with Myeloproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Natan, M; Distel, RJ; Frank, DA; Kuang, Y; Nelson, EA; Walker, SR | 1 |
1 other study(ies) available for pimozide and Myeloproliferative Disorders
| Article | Year |
|---|---|
Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells.
Topics: Anti-Dyskinesia Agents; Apoptosis; Drug Synergism; Enzyme Inhibitors; Humans; Janus Kinase 2; Myeloproliferative Disorders; Pimozide; STAT5 Transcription Factor; Tumor Cells, Cultured | 2012 |